• • • • • • Web https://distribute.notified.com/Preview/PnrArticlePreview?r=6875731&l=eng 1 of 8 3/14/2024, 5:08 PM

Web https://distribute.notified.com/Preview/PnrArticlePreview?r=6875731&l=eng 2 of 8 3/14/2024, 5:08 PM

• • • • • • • • • Web https://distribute.notified.com/Preview/PnrArticlePreview?r=6875731&l=eng 3 of 8 3/14/2024, 5:08 PM

Anticipated Timing Pivotal PK Studies Supportive PK Studies FDA Meetings / Actions Completed Phase 3 PK Study Repeat Dose PK Study Type C Meeting Q1 2024 Temperature PK Study Q2 2024 Self-administration PK Study Allergen PK Study Q3 2024 Pediatric PK Study H2 2024 Pre-NDA Meeting Web https://distribute.notified.com/Preview/PnrArticlePreview?r=6875731&l=eng 4 of 8 3/14/2024, 5:08 PM

Web https://distribute.notified.com/Preview/PnrArticlePreview?r=6875731&l=eng 5 of 8 3/14/2024, 5:08 PM

Web https://distribute.notified.com/Preview/PnrArticlePreview?r=6875731&l=eng 6 of 8 3/14/2024, 5:08 PM

Web https://distribute.notified.com/Preview/PnrArticlePreview?r=6875731&l=eng 7 of 8 3/14/2024, 5:08 PM

Web https://distribute.notified.com/Preview/PnrArticlePreview?r=6875731&l=eng 8 of 8 3/14/2024, 5:08 PM